Table 4.
Frequency of ESBL, MBL, MDR and XDR Among ESKAPE Pathogens
| Organism | MDR | XDR | ESBL | MBL | ||||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | |
| E.faecium | 20 | 80 | 5 | 20 | – | – | – | – |
| S.aureus | 102 | 67.5 | 1 | 0.6 | – | – | – | – |
| K. pneumoniae | 48 | 32.2 | 19 | 12.8 | 24 | 16.1 | 12 | 8.1 |
| A. baumannii | 12 | 30.76 | 12 | 30.76 | 4 | 10.3 | 4 | 10.3 |
| P. aeruginosa | 12 | 14.3 | 6 | 7.1 | 9 | 10.7 | 7 | 8.3 |
| E. aerogenes | 2 | 50 | 0 | 0 | 0 | 0 | 0 | 0 |
Abbreviations: ESBL, extended-spectrum β-lactamase; MBL, Metallo-β-lactamase; MDR, multi-drug resistant; XDR, extensively-drug resistant.